source
- French regulator fines Novo Nordisk and Eli Lilly for misleading weight loss adsFrench medicines regulator ANSM imposed fines on Novo Nordisk and Eli Lilly for advertising practices linked to their weight loss drugs. Novo Nordisk was fined about $2 million for ads promoting W…
- 5th Circuit reinstates in-person dispensing for mifepristone, prompting Supreme Court stay and industry concernsThe 5th Circuit Court of Appeals reversed a prior ruling and required mifepristone to be dispensed only in person. Danco, the drug's maker, asked the Supreme Court for relief and received a one-wee…